Febrile neutropenia in children with cancer

Advances in Experimental Medicine and Biology

Volumn 634, Issue , 2009, Pages 185-204

  Paulus, Stéphane ^a   Dobson, Simon ^a  

^a BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLAVULANATE POTASSIUM PLUS TICARCILLIN; ECHINOCANDIN; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; INTERLEUKIN 6; INTERLEUKIN 8; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; PROCALCITONIN; TEICOPLANIN; TOBRAMYCIN; TRIAZOLE DERIVATIVE; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTERIAL INFECTION; BLOOD CULTURE; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DRUG CHOICE; EARLY DIAGNOSIS; FEBRILE NEUTROPENIA; FEVER; GOOD CLINICAL PRACTICE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE INFECTION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HOSPITAL DISCHARGE; HUMAN; IN VITRO STUDY; LUNG ASPERGILLOSIS; MEDICAL DECISION MAKING; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MOUTH TEMPERATURE; NEUTROPENIA; NEUTROPHIL COUNT; OUTPATIENT CARE; OUTPATIENT DEPARTMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; TREATMENT OUTCOME; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIA (MICROORGANISMS); NEGIBACTERIA; POSIBACTERIA;

EID: 84934444263     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-79838-7_16     Document Type: Article

References (64)

1. Agaoglu L., Devecioglu O., Anak S., Karakas Z., Yalman N., Biner B., Eryilmaz E., Goksan B., Unuvar A., Agirbasli H., Can M., Bilgen H., Gedikoglu G. (2001) Cost-effectiveness of cefepime plus netilmicin or ceftazidime plus amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. J Chemother 13:281-287 (Pubitemid 32575141)
2. Ammann R. A., Aebi C., Hirt A., Luthy A. R. (2004) Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001. Support Care Cancer 12:826-832 (Pubitemid 40104776)
3. Ammann R. A., Hirt A., Luthy A. R., Aebi C. (2003) Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection. Med Pediatr Oncol 41:436-443 (Pubitemid 37229435)
4. Aquino V. M., Herrera L., Sandler E. S., Buchanan G. R. (2000) Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. Cancer 88:1710-1714 (Pubitemid 30183158)
5. Archibald S., Park J., Geyer J. R., Hawkins D. S. (2001) Computed tomography in the evaluation of febrile neutropenic pediatric oncology patients. Pediatr Infect Dis J 20:5-10 (Pubitemid 32066169)
6. Ariffin H., Ai C. L., Lee C. L., Abdullah W. A. (2006) Cefepime monotherapy for treatment of febrile neutropenia in children. J Paediatr Child Health 42:781-784 (Pubitemid 44690824)
7. Ariffin H., Arasu A., Mahfuzah M., Ariffin W. A., Chan L. L., Lin H. P. (2001) Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer. J Paediatr Child Health 37:38-43 (Pubitemid 32163511)
8. Ariffin H., Navaratnam P., Mohamed M., Arasu A., Abdullah W. A., Lee C. L., Peng L. H. (2000) Ceftazidime-resistant Klebsiella pneumoniae bloodstream infection in children with febrile neutropenia. Int J Infect Dis 4:21-25 (Pubitemid 30136621)
9. Arola M., Ruuskanen O., Ziegler T., Salmi T. T. (1995) Respiratory virus infections during anticancer treatment in children. Pediatr Infect Dis J 14:690-694
10. Blondell-Hill E., Bug and Drugs (4th Ed.), p. 37, Capital Health, Edmonton, AB (2006)
11. Boragina M., Patel H., Reiter S., Dougherty G. (2007) Management of febrile neutropenia in pediatric oncology patients: A Canadian survey. Pediatr Blood Cancer 48:521-526 (Pubitemid 46496346)
12. Bruckner L., Gigliotti F. (2002) Alpha-hemolytic streptococcal infections among immunocompromised hosts: Increasing incidence, severity and antibiotic resistance. Pediatr Infect Dis J 21:343-345 (Pubitemid 34326874)
13. Caillot D., Casasnovas O., Bernard A., Couaillier J. F., Durand C., Cuisenier B., Solary E., Piard F., Petrella T., Bonnin A., Couillault G., Dumas M., Guy H. (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 15:139-147 (Pubitemid 27020567)
14. Caillot D., Couaillier J. F., Bernard A., Casasnovas O., Denning D. W., Mannone L., Lopez J., Couillault G., Piard F., Vagner O., Guy H. (2001) Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 19:253-259 (Pubitemid 32063503)
15. Chamberlain J. D., Smibert E., Skeen J., Alvaro F. (2005) Prospective audit of treatment of paediatric febrile neutropenia in Australasia. J Paediatr Child Health 41:598-603 (Pubitemid 43961166)
16. Chambers H.; "Other B-Lactams Antibiotics" in Principles and Practice of Infectious Diseases p. 313, Elsevier Churchill Livingstone (2005)
17. Charnas R., Luthi A. R., Ruch W. (1997) Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Children. Pediatr Infect Dis J 16:346-353 (Pubitemid 27173246)
18. Chastagner P., Plouvier E., Eyer D., Plesiat P., Lozniewski A., Sommelet D. (2000) Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer. Med Pediatr Oncol 34:306-308 (Pubitemid 30176620)
19. Cometta A., Calandra T., Gaya H., Zinner S. H., de Bock R., Del Favero A., Bucaneve G., Crokaert F., Kern W. V., Klastersky J., Langenaeken I., Micozzi A., Padmos A., Paesmans M., Viscoli C., Glauser M. P. (1996) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrob Agents Chemother 40:1108-1115
20. Connell T. G., Rele M., Cowley D., Buttery J. P., Curtis N. (2007) How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 119:891-896 (Pubitemid 46715658)
21. Corapcioglu F., Sarper N. (2005) Cefepime versus ceftazidime plus amikacin as empirical therapy for febrile neutropenia in children with cancer: A prospective randomized trial of the treatment efficacy and cost. Pediatr Hematol Oncol 22:59-70 (Pubitemid 40054023)
22. Corapcioglu F., Sarper N., Zengin E. (2006) Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: A randomized comparison. Pediatr Hematol Oncol 23:177-186 (Pubitemid 43361800)
23. Duzova A., Kutluk T., Kanra G., Buyukpamukcu M., Akyuz C., Secmeer G., Ceyhan M. (2001) Monotherapy with meropenem versus combination therapy with piperacillin plus amikacin as empiric therapy for neutropenic fever in children with lymphoma and solid tumors. Turk J Pediatr 43:105-109 (Pubitemid 32537265)
24. El-Maghraby S. M., Moneer M. M., Ismail M. M., Shalaby L. M., El-Mahallawy H. A. (2007) The diagnostic value of c-reactive protein, interleukin-8. and monocyte chemotactic protein in risk stratification of febrile neutropenic children with Hematologic malignancies. J. Pediatr Hematol Oncol 29:131-136 (Pubitemid 46673396)
25. Fleischhack G., Hartmann C., Simon A., Wulff B., Havers W., Marklein G., Hasan C., Bode U. (2001) Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer. J Antimicrob Chemother 47:841-853 (Pubitemid 32519833)
26. Fouyssac F., Salmon A., Mansuy L., Schmitt C., Bordigoni P., Chastagner P. (2005) Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination. Medecine Et Maladies Infectieuses 35:357-362 (Pubitemid 41121936)
27. Gamis A. S., Howells W. B., DeSwarte-Wallace J., Feusner J. H., Buckley J. D., Woods W. G. (2000) Alpha hemolytic streptococcal infection during intensive treatment for acute myeloid leukemia:areport from the Children's cancer group study CCG-2891. JClin Oncol 18:1845-1855 (Pubitemid 30261922)
28. Glasmacher A., von Lilienfeld-Toal M., Schulte S., Hahn C., Schmidt-Wolf I. G., Prentice A. (2005) An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients. Clin Microbiol Infect 11 Suppl 5:17-23 (Pubitemid 41348481)
29. Granowetter L., Wells H., Lange B. J. (1988) Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient. Pediatr Infect Dis J 7:165-170 (Pubitemid 18086610)
30. Gray J. W., George R. H. (2000) Experience of vancomycin-resistant enterococci in a children's hospital. J Hosp Infect 45:11-18 (Pubitemid 30409320)
31. Hann I., Viscoli C., Paesmans M., Gaya H., Glauser M. (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 99:580-588
32. Hauggaard A., Ellis M., Ekelund L. (2002) Early chest radiography and CT in the diagnosis, management and outcome of invasive pulmonary aspergillosis. Acta Radiol 43:292-298
33. Heikkinen T., Marttila J., Salmi A. A., Ruuskanen O. (2002) Nasal swab versus nasopharyngeal aspirate for isolation of respiratory viruses. J Clin Microbiol 40:4337-4339 (Pubitemid 35285840)
34. Hoffer F. A., Gow K., Flynn P. M., Davidoff A. (2001) Accuracy ofpercutaneous lung biopsy for invasive pulmonary aspergillosis. Pediatr Radiol 31:144-152 (Pubitemid 32201378)
35. Hughes W. T., Armstrong D., Bodey G. P., Bow E. J., Brown A. E., Calandra T., Feld R., Pizzo P. A., Rolston K. V. I., Shenep J. L., Young L. S. (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34:730-751 (Pubitemid 34194843)
36. Hung K. C., Chiu H. H., Tseng Y. C., Wang J. H., Lin H. C., Tsai F. J., Peng C. T. (2003) Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. J Microbiol Immunol Infect 36:254-259
37. Ihendyane N., Sparrelid E., Wretlind B., Remberger M., Andersson J., Ljungman P., Ringden O., Normark B. H., Allen U., Low D. E., Norrby-Teglund A. (2004) Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines. Bone Marrow Transplant 33:79-85 (Pubitemid 38159708)
38. Innes H., Marshall E. (2007) Outpatient therapy for febrile neutropenia. Curr Opin Oncol 19:294-298 (Pubitemid 46883516)
39. Kennedy H. F., Gemmell C. G., Bagg J., Gibson B. E., Michie J. R. (2001) Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia. J Antimicrob Chemother 47:693-696 (Pubitemid 32447663)
40. Kitanovski L., Jazbec J., Hojker S., Gubina M., Derganc M. (2006) Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer. Eur J Clin Microbiol Infect Dis 25:413-415 (Pubitemid 43885690)
41. Klaassen R. J., Goodman T. R., Pham B., Doyle J. J. (2000) "Low-risk" prediction rule for pediatric oncology patients presenting with fever and neutropenia. J Clin Oncol 18:1012-1019 (Pubitemid 30123777)
42. Klastersky J., Paesmans M., Rubenstein E. B., Boyer M., Elting L., Feld R., Gallagher J., Herrstedt J., Rapoport B., Rolston K., Talcott J. (2000) The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18:3038-3051 (Pubitemid 30644129)
43. Le Guyader N., Auvrignon A., Vu-Thien H., Portier E., Tabone M. D., Leverger G. (2004) Piperacillin-tazobactam and netilmicin as a safe and efficacious empirical treatment of febrile neutropenic children. Support Care Cancer 12:720-724 (Pubitemid 39362651)
44. Lehrnbecher T., Varwig D., Kaiser J., Reinhardt D., Klingebiel T., Creutzig U. (2004) Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93. Leukemia 18:72-77 (Pubitemid 38159441)
45. Mullen C. A. (2003) Ciprofloxacin in treatment of fever and neutropenia in pediatric cancer patients. Pediatric Infectious Disease Journal 22:1138-1142 (Pubitemid 37543425)
46. Nourse C., Murphy H., Byrne C., O'Meara A., Breatnach F., Kaufmann M., Clarke A., Butler K. (1998) Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur J Pediatr 157:20-27 (Pubitemid 28128096)
47. Okamoto Y., Ribeiro R. C., Srivastava D. K., Shenep J. L., Pui C. H., Razzouk B. I. (2003) Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. J Pediatr Hematol Oncol 25:696-703 (Pubitemid 37087505)
48. Oude Nijhuis C., Kamps W. A., Daenen S. M., Gietema J. A., van der Graaf W. T., Groen H. J., Vellenga E., Ten Vergert E. M., Vermeulen K. M., de Vries-Hospers H. G., de Bont E. S. (2005) Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol 23:7437-7444 (Pubitemid 46291805)
49. Owens R. C., Owens C. A., Holloway W. J. (2000) Reduction in Vancomycin consumption in patients with fever and neutropenia [abstract 458]. Clin. Infect. Dis. 31:291
50. Paganini H., Staffolani V., Zubizarreta P., Casimir L., Lopardo H., Luppino V. (2003) Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors. Eur J Cancer 39:1284-1289 (Pubitemid 36579201)
51. Paul M., Soares-Weiser K., Grozinsky S., Leibovici L. (2003) Beta-lactam versus beta-lactamaminoglycoside combination therapy in cancer patients with neutropaenia. Cochrane Database Syst Rev 3: CD003038
52. Paulus S. C., van Saene H. K. F., Hemsworth S., Hughes J., Ng A., Pizer B. L. (2005) A prospective study of septicaemia on a paediatric oncology unit: A three-year experience at The Royal Liverpool Children's Hospital, Alder Hey, UK. Eur J Cancer 41:2132-2140 (Pubitemid 41337955)
53. Petrilli A., Altruda Carlesse F., Alberto Pires Pereira C. (2007) Oral gatifloxacin in the outpatient treatment of children with cancer fever and neutropenia. Pediatr Blood Cancer 49:682-686 (Pubitemid 350194435)
54. Phillips B., Selwood K., Lane S. M., Skinner R., Gibson F., Chisholm J. C. (2007) Variation in policies for the management of febrile neutropenia in United Kingdom Children's Cancer Study Group centres. Arch Dis Child 92:495-498 (Pubitemid 46867264)
55. Phillips R., Skinner R., Chisholm J. C. (2007) Treating low-risk febrile neutropenia: Jenny's story. Arch Dis Child 92:7-8 (Pubitemid 46132923)
56. Rondinelli P. I. P., Ribeiro K. D. B., de Camargo B. (2006) A proposed score for predicting severe infection complications in children with chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol 28:665-670 (Pubitemid 44540164)
57. Santolaya M. E., Alvarez A. M., Aviles C. L., Becker A., Cofre J., Cumsille M. A., O'Ryan M. L., Paya E., Salgado C., Silva P., Tordecilla J., Varas M., Villarroel M., Viviani T., Zubieta M. (2004) Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. J Clin Oncol 22:3784-3789 (Pubitemid 41095219)
58. Santolaya M. E., Alvarez A. M., Becker A., Cofre J., Enriquez N., O'Ryan M., Paya E., Pilorget J., Salgado C., Tordecilla J., Varas M., Villarroel M., Viviani T., Zubieta M. (2001) Prospective, multicenter evaluation of risk factors associated with invasive bacterial infection in children with cancer, neutropenia, and fever. J Clin Oncol 19:3415-3421 (Pubitemid 32642195)
59. Schuster F., Graubner U. B., Schmid I., Weiss M., Belohradsky B. H. (1998) Vancomycinresistant-enterococci - colonization of 24 patients on a pediatric oncology unit. Klin Padiatr 210:261-263 (Pubitemid 28361250)
60. Stryjewski G. R., Nylen E. S., Bell M. J., Snider R. H., Becker K. L., Wu A., Lawlor C., Dalton H. (2005) Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6:129-135 (Pubitemid 40724303)
61. Tager F. M., Zolezzi R. P., Folatre B. I., Navarrete C. M., Rojas P. J. (2006) Respiratory virus infections in children with acute lymphoblastic leukemia and febrile neutropenia: a prospective study. Rev Chilena Infectol 23:118-123 (Pubitemid 43807104)
62. Thomas K. E., Owens C. M., Veys P. A., Novelli V., Costoli V. (2003) The radiological spectrum of invasive aspergillosis in children: a 10-year review. Pediatr Radiol 33:453-460 (Pubitemid 36833728)
63. Viscoli C., Castagnola E. "Prophylaxis and Empirical Therapy for Infection in Cancer Patients" in Principles and Practice of Infectious Diseases (6th Ed), pp. 3442-3462, Elsevier Churchill Livingstone (2005).
64. Walsh T. J., Groll, A., Gonzalez C., Pizzo, P. "Infectious Complications in Pediatric Cancer Patients" in Principles and Practice of Pediatric Oncology (5th Ed.), pp. 1269-1329, Lippincott Williams & Wilkins (2005)